BSECompany Update1d ago · 4 Sept 2026, 12:35 pm

We are enclosing herewith the Newspaper Publication for the 9th Annual General Meeting of the Company.

Senores Pharmaceuticals Ltd · 544319

✦ AI SummaryResults

Senores Pharmaceuticals Ltd has published a newspaper advertisement for its 9th Annual General Meeting, as per Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Attachments (1)

📄

3cc82321-8604-4eae-88e6-1fb78c17470f.pdf

pdf

Download →
View document text
Date: September 04, 2026 To, To, Sr. General Manager Sr. General Manager Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street Bandra Kurla Complex Mumbai – 400 001 Bandra (E), Mumbai – 400 051 BSE Scrip Code: 544319 NSE Symbol: SENORES Sub.: Newspaper Advertisement – Nineth (9th) Annual General Meeting of the Members of the Company Dear Sir/Madam, Pursuant to Regulation 30 aof the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copies of the Newspaper Advertisement published, in Financial Express –English (All India Edition) and Gujarati Edition, in connection with the Nineth (9th ) Annual General Meeting of the of the Company. This intimation is also being uploaded on the website of the Company i.e. www.senorespharma.com. You are requested to take the same on record. Thanking you. For Senores Pharmaceuticals Limited Shilpa Sharma Company Secretary and Compliance Officer ICSI Membership No.: A34516 Enclosures: As above Senores Pharmaceuticals Limited 1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad-380054, Gujarat, India P: +91 79 2999 9857 | E: info@senorespharma.com W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263 CIN:L51909GJ1992PLC017742 Aû¼ÌAÿ¼ : cs@vinnyoverseas.in ¡¼Ìù¼¬¼¼Ch: www.vinnyoverseas.in www.bseindia.com@¼‡¼Ì www.nseindia.com@¼‡¼Ì ‡¼Ì£¼‡¼ÿ¼ ½¬¼Lü¼¼Ì(cid:149)ÂhÂd ½mм¼ÌdÂh(cid:149) 7000 @¼‡¼Ì 022- 2499 7000 Eм(cid:149) K¼Ìÿ¼ K(cid:149)¡¼¼Ì @¼x¼¡¼¼ evoting@nsdl.co.in ‡¼Ì @¼(cid:149)_ t¼¼(cid:149)ÂQ¼: 04 ¬¼ŠhÌûù¼(cid:149), 2026 ½°(cid:149)¼ÿ¼¼ÿ¼ ]S¼½y£¼[¼Z„ м¼(cid:149)ÌQ¼ CIN: U24290GJ2017PLC100263 ¡¼Ìù¼¬¼¼Ch :www.senorespharma.comÙ Cû¼ÌCÿ¼ :cs@senorespharma.com ö¼Ì‡¼ : +91-79-29999857 https://instavote.linkintime.co.in Eм(cid:149) мr¼ Eмÿ¼ù†¼ (cid:149)°Ì£¼Ì. enotices@in.mpms.mufg.com‡¼Ì Cû¼ÌCÿ¼ ÿ¼Q¼Â‡¼Ì @¼x¼¡¼¼ hÌÿ¼Â: 022-4918 6000 Eм(cid:149) K¼Ìÿ¼ t¼¼(cid:149)ÂQ¼ : 04.09.2026 û¼Ì‡¼Ì½]ZS¼ m¼ü¼(cid:149)ÌLh(cid:149)